These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33094274)

  • 1. Nephron Number and Time to Remission in Steroid-Sensitive Minimal Change Disease.
    Sasaki T; Tsuboi N; Marumoto H; Okabayashi Y; Haruhara K; Kanzaki G; Koike K; Ogura M; Ninomiya T; Yokoo T
    Kidney Med; 2020; 2(5):559-568.e1. PubMed ID: 33094274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network.
    Chen DP; Helmuth ME; Smith AR; Canetta PA; Ayoub I; Mucha K; Kallash M; Kopp JB; Gbadegesin R; Gillespie BW; Greenbaum LA; Parekh RS; Hunley TE; Sperati CJ; Selewski DT; Kidd J; Chishti A; Reidy K; Mottl AK; Gipson DS; Srivastava T; Twombley KE;
    Am J Kidney Dis; 2023 Jun; 81(6):695-706.e1. PubMed ID: 36608921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for minimal change disease in adults with nephrotic syndrome.
    Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome.
    Hodgin JB; Mariani LH; Zee J; Liu Q; Smith AR; Eddy S; Hartman J; Hamidi H; Gaut JP; Palmer MB; Nast CC; Chang A; Hewitt S; Gillespie BW; Kretzler M; Holzman LB; Barisoni L;
    Am J Kidney Dis; 2022 Jun; 79(6):807-819.e1. PubMed ID: 34864148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.
    Elsherbiny HE; Alexander MP; Kremers WK; Park WD; Poggio ED; Prieto M; Lieske JC; Rule AD
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1892-902. PubMed ID: 25318758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Takeda A; Tsukamoto T; Uchida S; Tsuruya K; Shoji T; Hayashi H; Akai Y; Fukunaga M; Konta T; Nishio S; Goto S; Tamai H; Nagai K; Katafuchi R; Masutani K; Wada T; Nishino T; Shirasaki A; Sobajima H; Nitta K; Yamagata K; Kazama JJ; Hiromura K; Yasuda H; Mizutani M; Akahori T; Naruse T; Hiramatsu T; Morozumi K; Mimura T; Saka Y; Ishimura E; Hasegawa H; Ichikawa D; Shigematsu T; Sato H; Narita I; Isaka Y;
    J Nephrol; 2022 May; 35(4):1135-1144. PubMed ID: 35366214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Remission in the Nephrotic Syndrome Study Network.
    Gipson DS; Troost JP; Lafayette RA; Hladunewich MA; Trachtman H; Gadegbeku CA; Sedor JR; Holzman LB; Moxey-Mims MM; Perumal K; Kaskel FJ; Nelson PJ; Tuttle KR; Bagnasco SM; Hogan MC; Dell KM; Appel GB; Lieske JC; Ilori TO; Sethna CB; Fervenza FC; Hogan SL; Nachman PH; Rosenberg AZ; Greenbaum LA; Meyers KE; Hewitt SM; Choi MJ; Kopp JB; Zhdanova O; Hodgin JB; Johnstone DB; Adler SG; Avila-Casado C; Neu AM; Hingorani SR; Lemley KV; Nast CC; Brady TM; Barisoni-Thomas L; Fornoni A; Jennette JC; Cattran DC; Palmer MB; Gibson KL; Reich HN; Mokrzycki MH; Sambandam KK; Zilleruelo GE; Licht C; Sampson MG; Song P; Mariani LH; Kretzler M
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):81-9. PubMed ID: 26656320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
    Ozeki T; Katsuno T; Hayashi H; Kato S; Yasuda Y; Ando M; Tsuboi N; Hagiwara D; Arima H; Maruyama S
    Am J Nephrol; 2019; 49(1):54-63. PubMed ID: 30557879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Improved Method for Estimating Nephron Number and the Association of Resulting Nephron Number Estimates with Chronic Kidney Disease Outcomes.
    Denic A; Mullan AF; Alexander MP; Wilson LD; Augustine J; Luehrs AC; Stegall MD; Kline TL; Sharma V; Thompson RH; Rule AD
    J Am Soc Nephrol; 2023 Jul; 34(7):1264-1278. PubMed ID: 36958059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults.
    Koike K; Tsuboi N; Utsunomiya Y; Kawamura T; Hosoya T
    Am J Nephrol; 2011; 34(6):542-8. PubMed ID: 22123493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular Density and Volume in Renal Biopsy Specimens of Children with Proteinuria Relative to Preterm Birth and Gestational Age.
    Koike K; Ikezumi Y; Tsuboi N; Kanzaki G; Haruhara K; Okabayashi Y; Sasaki T; Ogura M; Saitoh A; Yokoo T
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):585-590. PubMed ID: 28336816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study.
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Takeda A; Uchida S; Tsukamoto T; Tsuruya K; Akai Y; Nitta K; Fukunaga M; Hayashi H; Masutani K; Wada T; Konta T; Katafuchi R; Nishio S; Goto S; Tamai H; Shirasaki A; Shoji T; Nagai K; Nishino T; Yamagata K; Kazama JJ; Hiromura K; Yasuda H; Mizutani M; Naruse T; Hiramatsu T; Morozumi K; Sobajima H; Saka Y; Ishimura E; Ichikawa D; Shigematsu T; Sofue T; Fujimoto S; Ito T; Sato H; Narita I; Isaka Y;
    Sci Rep; 2022 Jun; 12(1):9782. PubMed ID: 35697724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis.
    Huang JJ; Hsu SC; Chen FF; Sung JM; Tseng CC; Wang MC
    Am J Nephrol; 2001; 21(1):28-34. PubMed ID: 11275629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Nephron GFR in Patients With Obesity-Related Glomerulopathy.
    Okabayashi Y; Tsuboi N; Sasaki T; Haruhara K; Kanzaki G; Koike K; Shimizu A; D'Agati VD; Yokoo T
    Kidney Int Rep; 2020 Aug; 5(8):1218-1227. PubMed ID: 32775821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of minimal change disease without nephrotic range proteinuria.
    Son HE; Yun G; Kwon EJ; Park S; Jeong JC; Kim S; Na KY; Paik JH; Chin HJ
    PLoS One; 2023; 18(8):e0289870. PubMed ID: 37590275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.
    Shinzawa M; Yamamoto R; Nagasawa Y; Oseto S; Mori D; Tomida K; Hayashi T; Izumi M; Fukunaga M; Yamauchi A; Tsubakihara Y; Isaka Y
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1040-8. PubMed ID: 24721890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
    Chin HJ; Chae DW; Kim YC; An WS; Ihm C; Jin DC; Kim SG; Kim YL; Kim YS; Kim YG; Koo HS; Lee JE; Lee KW; Oh J; Park JH; Jiang H; Lee H; Lee SK
    J Am Soc Nephrol; 2021 Jan; 32(1):199-210. PubMed ID: 33168602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.